What trends are driving change this year in the life sciences industry? Amanda Laskey and Brian Winne, senior analysts for the life sciences industry at RSM, share their insights. Watch this short video. Top trends for life sciences GLP-1 This class of drugs, originally developed for diabetes, is now showing promise in treating obesity and other metabolic disorders. The potential market for GLP-1 therapies in biopharma is enormous, and companies are racing to develop new treatments.